image
Rocket Pharmaceuticals, Inc. RCKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.7
-19.6 %
$ 715 M
Market Cap
-2.31
P/E
BALANCE SHEET
528 M ASSETS
-6.82%
Growth Rates
1Year -6.82%
3Years 2.02%
5Years 7.24%
7Years 26.50%
10Years 57.78%
64.5 M LIABILITIES
-12.61%
Growth Rates
1Year -12.61%
3Years 15.08%
5Years -0.11%
7Years 2.56%
10Years 1.22%
463 M EQUITY
-5.96%
Growth Rates
1Year -5.96%
3Years 0.62%
5Years 8.55%
7Years 38.34%
10Years 27.08%
BALANCE SHEET DECOMPOSITION
Balance Sheet Rocket Pharmaceuticals, Inc.
image
Current Assets 378 M
Cash & Short-Term Investments 372 M
Receivables 0
Other Current Assets 5.85 M
Non-Current Assets 150 M
Long-Term Investments 0
PP&E 83.3 M
Other Non-Current Assets 66.2 M
70.56 %15.79 %12.54 %Total Assets$527.7m
Current Liabilities 40.7 M
Accounts Payable 0
Short-Term Debt 2.86 M
Other Current Liabilities 37.8 M
Non-Current Liabilities 23.8 M
Long-Term Debt 0
Other Non-Current Liabilities 23.8 M
4.43 %58.68 %36.89 %Total Liabilities$64.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 163.6 55.9 140.5 232.7 297.1 185.4 111.4 78.7 29.8 80.0 3.6 12.8 1.4
Short Term Investments 208.7 317.3 215.9 156.0 185.6 118.7 94.4 21.3 96.7 31.2 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 5.8 5.0 7.7 6.6 9.3 7.3 6.7 1.0 1.9 2.2 0.1 66 K 45 K
Total Current Assets 378.2 378.2 364.1 392.1 487.3 307.8 209.1 101.0 128.3 112.4 3.6 12.9 1.4
PP&E 83.3 87.6 77.6 72.3 70.6 31.3 2.0 0.6 1.1 0.8 0 0 0
Intangible Assets 25.1 25.1 25.7 0 0 0.2 0 0 0 0 0 0 0
Goodwill 39.2 39.2 39.2 30.8 30.8 30.8 30.8 0 0 0 0 0 0
Long Term Investments 0 34.3 43.3 1.3 1.6 1.5 7.4 0.2 0 0 0 0 0
Other Long Term Assets 1.9 1.9 1.9 1.8 2.0 2.0 1.4 39 K 0.2 0.1 1.9 4 K 4 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 527.7 566.3 551.8 497.0 590.8 372.1 251.3 101.8 129.6 113.3 5.5 12.9 1.4
LIABILITIES
Accounts Payable 0 0 0 0 0 0 0 0.5 1.6 1.6 1.1 0.2 0.4
Short Term Debt 2.9 2.7 5.0 5.1 9.4 1.9 0 0 0 0 5.1 0.7 2.2
Other Current Liabilities 37.8 45.8 34.2 17.1 23.2 16.4 15.4 3.1 5.6 2.5 (2.5) 1.2 0.3
Total Current Liabilities 40.7 48.5 39.2 22.2 32.6 18.3 15.4 4.1 7.2 4.1 3.7 3.2 3.8
Long Term Debt 0 22.3 40.7 40.1 74.0 47.9 41.4 49.5 49.0 0 2.5 5.4 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 23.8 2.9 (17.8) (20.0) (19.4) (1.4) 0.5 0.4 0.3 0.4 50.8 43.1 28.6
Total Liabilities 64.5 73.8 62.1 42.3 87.3 64.8 57.3 54.0 56.5 4.5 57.1 51.8 32.4
EQUITY
Common Stock 1.1 0.9 0.8 0.6 0.6 0.5 0.5 68 K 0.3 0.3 10 K 10 K 10 K
Retained Earnings (1 218.1) (959.4) (713.8) (491.9) (322.8) (183.1) (105.9) (268.4) (238.9) (196.0) (128.0) (118.5) (110.9)
Other Accumulative Comprehensive Income/Loss 66 K 0.3 (0.4) (0.2) 42 K 20 K (0.1) 16 K 54 K 11 K (0.2) (0.2) (0.2)
Total Equity 463.2 492.6 489.7 454.7 503.5 307.3 194.0 47.8 73.2 108.8 (51.6) (38.9) (30.9)
Total Liabilities and Equity 527.7 566.3 551.8 497.0 590.8 372.1 251.3 101.8 129.6 113.3 5.5 12.9 1.4
SHARES OUTSTANDING
Common Shares Outstanding 94.8 84.0 68.1 63.2 55.4 49.0 39.4 6.8 6.7 4.6 3.4 2.1 2.1